Targeting EGFR with photodynamic therapy in combination with Erbitux enhances in vivo bladder tumor response. [electronic resource]
Producer: 20100205Description: 94 p. digitalISSN:- 1476-4598
- Animals
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Apoptosis -- drug effects
- Cetuximab
- Combined Modality Therapy
- ErbB Receptors -- antagonists & inhibitors
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Mice
- Phosphorylation -- drug effects
- Photochemotherapy
- Remission Induction
- Urinary Bladder Neoplasms -- drug therapy
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.